Article Versions Notes

Herlah B, Hoivik A, Jamšek L, Valjavec K, Yamamoto N, Hoshino T, Kranjc K, Perdih A. Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL^pro Main Protease. Pharmaceuticals. 2022; 15(5):539. https://doi.org/10.3390/ph15050539

Herlah, Barbara, Andrej Hoivik, Luka Jamšek, Katja Valjavec, Norio Yamamoto, Tyuji Hoshino, Krištof Kranjc, and Andrej Perdih. 2022. "Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL^pro Main Protease" Pharmaceuticals 15, no. 5: 539. https://doi.org/10.3390/ph15050539

Herlah, B., Hoivik, A., Jamšek, L., Valjavec, K., Yamamoto, N., Hoshino, T., Kranjc, K., & Perdih, A. (2022). Design, Synthesis and Evaluation of Fused Bicyclo[2.2.2]octene as a Potential Core Scaffold for the Non-Covalent Inhibitors of SARS-CoV-2 3CL^pro Main Protease. Pharmaceuticals, 15(5), 539. https://doi.org/10.3390/ph15050539